| New drug to tackle MS mobility disorders Press TV Sat, 07 Jun 2008 19:22:25 |
| A newly developed medicine has shown promising results in fighting mobility disorders in patients suffering from multiple sclerosis. According to the new reports, frampridine improves walking skills in two-fifths of the patients taking the drug and positively influences leg strength in the majority of these individuals. Findings revealed that the medication made by Acorda co. improves the condition by slowing the loss of potassium from nerve cells caused by the underlying disease. The study reported that while the drug improved mobility in some patients, it had no effect on the overall speed of the disease in such individuals. British MS Society researches believe the new drug has a considerable impact on the quality of life in MS patients particularly those who are still capable of walking, but at a slow pace and with difficulty. Multiple sclerosis is an autoimmune condition in which the immune system attacks the myelin covering the nerve cells, leading to numerous physical and mental symptoms including limb weakness, blurred vision and balance problems. PKH/HGH |
ABOUT this BLOG and How to use it
Like this blog? - CLICK "LIKE"
Sunday, June 8, 2008
New drug (frampridine) to tackle MS mobility disorders
Subscribe to:
Post Comments (Atom)
1 comments:
From what I understand, because Fampridine can be used in conjunction with other therapies (the ABCRs & Tysabri), the MS patient does not have to switch therapies, but only consider Fampridine as an "add-on" therapy to assist them with their walking, if they are still ambulatory.
Fampridine does not alter the immune system, so it is apparently safe as an "add-on" therapy for the patient, plus it's a pill, yaaay!
I think this is wonderful news for the appropriate MS community.
Jmho, Lauren :)
Post a Comment